Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity
Assessing The Role Of Intravenous Lipid Emulsion As A Life Saving Therapy In Pesticides Toxicity: A Randomized Controlled Trial In Poison Control Center Of Ain Shams University Hospitals
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Contact
Study Contact
- Name: Aya Sabry Mohamed
- Phone Number: +201013910938
- Email: dr.ayasabry@gmail.com
Study Locations
-
-
Abbasya
-
Cairo, Abbasya, Egypt, 11311
- Recruiting
- Poison Control Center of Ain-Shams University hospitals
-
Contact:
- Aya Sabry Mohamed
- Phone Number: +201013910938
- Email: dr.ayasabry@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with acute pesticide intoxications with poison severity score 2 or 3 admitted in ICU of PCC-ASUH
Exclusion Criteria:
- Patients less than 18 years and more than 65 years.
- Pregnant and lactating females.
- Presence of medical diseases (e.g. renal, hepatic, cardiovascular, neurological diseases and chronic pancreatitis.)
- Allergy to soya-, egg-or peanut protein
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: control group
will receive the traditional supportive treatment according to (PCC-ASUH) protocol
|
standard of care for treatment of aluminuim phosphide is provided for patients poisoned with aluminuim phosphide
a drug used as an antidote for some types of pesticides
a drug used as an antidote for some types of pesticides
|
|
Active Comparator: case group
will receive the traditional supportive treatment plus administration of ILE (20%) 1.5 ml/kg as a bolus over 2-3 minutes.
Followed immediately by an infusion of 20 % lipid emulsion at a rate of 0.25 mL/kg/min.
After 3 minutes of this infusion rate, response to the bolus and initial infusion should be assessed.
If there has been a significant response, the infusion rate can be adjusted to 0.025 mL/kg/min with monitoring of blood pressure, heart rate, and other available hemodynamic parameters during the infusion with a maximum dose of 10 mL/kg
|
standard of care for treatment of aluminuim phosphide is provided for patients poisoned with aluminuim phosphide
a drug used as an antidote for some types of pesticides
a drug used as an antidote for some types of pesticides
Lipid emulsion is a mixture of soybean oil, egg phospholipids, glycerine, and is available in 10%, 20%, and 30% strengths.
It has been used for decades as parenteral nutrition and for caloric supplementation and essential fatty acid deficiency.
It has also been used as a carrier for lipid soluble medications
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
organ damage reduction
Time Frame: 1 year
|
another primary end point is to reduce organ damage and injury for survivors
|
1 year
|
|
mortality rate reduction
Time Frame: 1 year
|
the primary end point is to lower the mortality rate for patients poisoned with pesticides
|
1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Chemically-Induced Disorders
- Poisoning
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Central Nervous System Depressants
- Parasympatholytics
- Autonomic Agents
- Peripheral Nervous System Agents
- Muscarinic Antagonists
- Cholinergic Antagonists
- Cholinergic Agents
- Antiemetics
- Gastrointestinal Agents
- Dermatologic Agents
- Antipsychotic Agents
- Tranquilizing Agents
- Psychotropic Drugs
- Serotonin Agents
- Serotonin Antagonists
- Adjuvants, Anesthesia
- Anti-Anxiety Agents
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Antipruritics
- Pharmaceutical Solutions
- Parenteral Nutrition Solutions
- Mydriatics
- Cholinesterase Reactivators
- Enzyme Reactivators
- Atropine
- Ondansetron
- Fat Emulsions, Intravenous
- Obidoxime Chloride
Other Study ID Numbers
Other Study ID Numbers
- MD27/2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.